Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature Medicine 10, 123 - 124 (2004)
doi:10.1038/nm0204-123
Sweet relief for Huntington disease
Masahisa Katsuno1, Hiroaki Adachi1 & Gen Sobue1
- Masahisa Katsuno, Hiroaki Adachi and Gen Sobue are in the Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan. e-mail: sobueg@med.nagoya-u.ac.jp
Abstract
Oral delivery of a simple, nontoxic sugar molecule alleviates symptoms of Huntington disease in a mouse model (pages 148–154).
A CAG repeat was first pinned to a neurological disorder—spinal and bulbar muscular atrophy (SBMA)—in 1991 (ref. 1).
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Polyglutamine neurodegeneration: minding your Ps and QsNature Medicine News and Views (01 Jul 2003)
The expanding world of ataxinsNature Genetics News and Views (01 Nov 1996)
See all 8 matches for News And ViewsRESEARCH
Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophyNature Medicine Article (01 Jun 2003)
17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degenerationNature Medicine Article (01 Oct 2005)
See all 8 matches for Research